
Why It’s Time to Re-evaluate Your Old Fill/Finish CDMO
Changing fill/finish CDMO With the costs to produce and package a drug climbing, companies are justifiably risk averse when it comes to changing fill/finish CDMOs. Why would you try a
Changing fill/finish CDMO With the costs to produce and package a drug climbing, companies are justifiably risk averse when it comes to changing fill/finish CDMOs. Why would you try a
Message from Argonaut CEO Wayne Woodard – Global Increase in Diagnostics Manufacturing Demand I hope you are doing well and staying healthy in this challenging time of unprecedented change. I
Life science cold chain shipping logistics The COVID-19 pandemic has added complexity to global shipping logistics. There is general market disruption in industry delivery. Airline freight rates are rising as cargo
Immediate COVID-19 Vaccine & Therapeutic Fill Finish Production Availability Announced by Argonaut Manufacturing Services Advanced Facility Readies to Combat COVID-19 (Carlsbad, CA) March 23, 2020 – Argonaut Manufacturing Services announced
The pandemic revealed need for pharmaceutical and diagnostics surge capacity The global COVID-19 outbreak has served as an important lesson for companies worldwide on the importance of supply chain integrity
Open Biopharma and Argonaut Manufacturing Services selected to host BIO International Ecosystem Tour in North County, San Diego CARLSBAD, CA, Mar. 3, 2020 Open Biopharma Research and Training Institute and
Providing customers with high standards – Particle Measuring Systems (PMS) and Argonaut Manufacturing Services partnering Partnership leverages their individual strengths to achieve high quality, reliable drug product manufacturing. February 25,
BioSkryb Partners with Argonaut Manufacturing Services to Accelerate Production of Key Genomic Amplification Products Argonaut will assemble kits and reagents for use in R&D, clinical research, and commercial systems DURHAM,
Comparing competing biotech manufacturer quotes is the final step in selecting your biotech contract manufacturing organization (CMO). While it may sound straightforward, due to a lack of industry standardization quotes
Most research and development teams seeking to construct ambient products will encounter the challenges of protein lyophilization. A primary obstacle is enzyme and antibody instability outside of native conditions, as